Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 23, 17 Issues, 2022
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets , Volume 17 - Number 12







Review Article

Redox-Related Mechanisms to Rebalance Cancer-Deregulated Cell Growth

, 17(12): 1414 - 1437

An-Sofie Stevens, Nicky Pirotte, Annelies Wouters, Andromeda Van Roten, Frank Van Belleghem, Maxime Willems, Ann Cuypers, Tom Artois and Karen Smeets


DOI: 10.2174/1389450116666150506112817


Review Article

Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?

, 17(12): 1438 - 1451

Zbynek Heger, Miguel Angel Merlos Rodrigo, Sona Krizkova, Branislav Ruttkay-Nedecky, Marta Zalewska, Elena Maria Planells del Pozo, Aurelie Pelfrene, Bertrand Pourrut, Marie Stiborova, Tomas Eckschlager, Gabriella Emri, Rene Kizek and Vojtech Adam


DOI: 10.2174/1389450116666151001113304



Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog